Provided by Tiger Trade Technology Pte. Ltd.

VistaGen Therapeutics

0.2438
-0.0002-0.08%
Pre-market: 0.24440.0006+0.25%05:44 EDT
Volume:477.88K
Turnover:115.44K
Market Cap:10.82M
PE:-0.15
High:0.2481
Open:0.2394
Low:0.2355
Close:0.2440
52wk High:5.14
52wk Low:0.1980
Shares:44.38M
Float Shares:41.42M
Volume Ratio:0.44
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6559
EPS(LYR):-1.8303
ROE:-166.46%
ROA:-83.21%
PB:0.44
PE(LYR):-0.13

Loading ...

VistaGen says FDA clears refisolone IND to proceed with Phase 2 studies

Reuters
·
Apr 29

AbCellera target is profile more attractive than Vistagen, says JonesResearch

TIPRANKS
·
Apr 22

VistaGen says FDA clears Phase 2 refisolone study for menopausal hot flashes

Reuters
·
Apr 22

Vistagen Receives FDA “Study May Proceed” Letter Under Its Refisolone Ind Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) Due to Menopause

THOMSON REUTERS
·
Apr 22

Vistagen Therapeutics Inc - FDA Letter Enables Further Phase 2 Development of Refisolone in the U.S.

THOMSON REUTERS
·
Apr 22

VistaGen Therapeutics Grants Broad Employee Retention Stock Options

TIPRANKS
·
Apr 14

VistaGen grants retention stock options to executives at $0.54 per share

Reuters
·
Apr 14

VistaGen flags Nasdaq noncompliance after audit committee falls below three members

Reuters
·
Apr 03

VistaGen director Mary Rotunno resigns effective April 1, 2026

Reuters
·
Mar 19

Class action lawsuit targets VistaGen over alleged misleading fasedienol trial statements

Reuters
·
Mar 13

BUZZ-Vistagen cuts 20% of staff to extend cash runway, shares fall

Reuters
·
Mar 11

Class action lawsuit targets VistaGen Therapeutics over alleged misleading clinical trial statements

Reuters
·
Mar 11

BRIEF-Vistagen Therapeutics Implements 20% Workforce Reduction

Reuters
·
Mar 11

VistaGen Therapeutics implements 20% workforce reduction

Reuters
·
Mar 11

Vistagen Therapeutics Inc - Affected Employees May Receive Cash Severance and Temporary Healthcare Coverage - SEC Filing

THOMSON REUTERS
·
Mar 11

Vistagen Therapeutics Inc - Expects Costs From Workforce Reduction to Be Immaterial - SEC Filing

THOMSON REUTERS
·
Mar 11

Class Action Lawsuit Targets VistaGen Therapeutics Over Misleading Trial Claims

Reuters
·
Mar 05

Pomerantz Files Securities Class Action Against VistaGen Therapeutics

Reuters
·
Mar 04

VistaGen to Participate in Leerink Healthcare Conference and Stifel 2026 Virtual CNS Forum

Reuters
·
Mar 03

Schall Law Firm Files Securities Fraud Class Action Against VistaGen Therapeutics

Reuters
·
Mar 03